Systemic mirRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works matching IS 10837159 AND DT 2010 AND VI 15 AND IP 7
Results: 20
1
2
Adjuvant high-dose interferon-[alpha] for resected melanoma in a patient with HIV infection.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Underuse of anthracyclines in women with HER2+ advanced breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Academia-Pharma intersect. Effect of patient age on management decisions in breast cancer: consensus from a national consultation.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
Temsirolimus: Is Improved Survival the Correct Expression of Drug Activity?
- Published in:
- 2010
- By:
- Publication type:
- Letter
6
Measuring circulating mirRNAS: the new 'PSA' for breast cancer?
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
7
How Accurate Are Physicians in the Prediction of Patient Survival in Advanced Lung Cancer?
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 782, doi. 10.1634/theoncologist.2009-0149
- By:
- Publication type:
- Article
8
Mucosal Melanomas: A Case-Based Review of the Literature.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 772, doi. 10.1634/theoncologist.2010-0067
- By:
- Publication type:
- Article
9
Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 765, doi. 10.1634/theoncologist.2009-0237
- By:
- Publication type:
- Article
10
Connection: Schwartz Center Rounds at Massachusetts General Hospital Cancer Center.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 760, doi. 10.1634/theoncologist.2009-0329
- By:
- Publication type:
- Article
11
Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Response Assessment Before High-Dose Chemotherapy for Lymphoma: A Systematic Review and Meta-Analysis.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 750, doi. 10.1634/theoncologist.2010-0054
- By:
- Publication type:
- Article
12
Major Molecular Response in CML Patients Treated with Tyrosine Kinase Inhibitors: The Paradigm for Monitoring Targeted Cancer Therapy.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 744, doi. 10.1634/theoncologist.2010-0055
- By:
- Publication type:
- Article
13
High Expression of Macrophage Colony-Stimulating Factor-1 Receptor in Peritumoral Liver Tissue Is Associated with Poor Outcome in Hepatocellular Carcinoma After Curative Resection.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 732, doi. 10.1634/theoncologist.2009-0170
- By:
- Publication type:
- Article
14
A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 699, doi. 10.1634/theoncologist.2010-0025
- By:
- Publication type:
- Article
15
Measuring Circulating miRNAs: The New "PSA" for Breast Cancer?
- Published in:
- 2010
- By:
- Publication type:
- Editorial
16
Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 683, doi. 10.1634/theoncologist.2009-0235
- By:
- Publication type:
- Article
17
Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 673, doi. 10.1634/theoncologist.2010-0103
- By:
- Publication type:
- Article
18
Effect of Patient Age on Management Decisions in Breast Cancer: Consensus from a National Consultation.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 657, doi. 10.1634/theoncologist.2009-0284
- By:
- Publication type:
- Article
19
Adjuvant High-Dose Interferon-α for Resected Melanoma in a Patient with HIV Infection.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
20
Underuse of Anthracyclines in Women with HER-2<sup>+</sup> Advanced Breast Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 665, doi. 10.1634/theoncologist.2010-0016
- By:
- Publication type:
- Article